.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
Merck
Covington
Novartis
Citi
Baxter
Moodys
Medtronic
Boehringer Ingelheim

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075809

« Back to Dashboard
NDA 075809 describes ENPRESSE-28, which is a drug marketed by Duramed Pharms Barr and is included in one NDA. It is available from three suppliers. Additional details are available on the ENPRESSE-28 profile page.

The generic ingredient in ENPRESSE-28 is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

Summary for NDA: 075809

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 075809

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ENPRESSE-21
ethinyl estradiol; levonorgestrel
TABLET;ORAL-21 075809 ANDA Teva Pharmaceuticals USA, Inc. 0555-9047 0555-9047-58 6 POUCH in 1 CARTON (0555-9047-58) > 1 BLISTER PACK in 1 POUCH > 1 KIT in 1 BLISTER PACK
ENPRESSE-21
ethinyl estradiol; levonorgestrel
TABLET;ORAL-21 075809 ANDA Rebel Distributors Corp 21695-855 21695-855-01 6 POUCH in 1 CARTON (21695-855-01) > 1 BLISTER PACK in 1 POUCH > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-21Strength0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG
Approval Date:Jul 16, 2001TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG
Approval Date:Jul 16, 2001TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Julphar
UBS
Moodys
Federal Trade Commission
Fish and Richardson
Teva
Novartis
McKinsey
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot